2-methyl-1-[[4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]methyl]-3-(3-phenylpropyl)guanidine;hydroiodide

C25H38IN5 — CID 111198739

IUPAC2-methyl-1-[[4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]methyl]-3-(3-phenylpropyl)guanidine;hydroiodide
SMILESC/N=C(\NCCCc1ccccc1)NCc1ccc(CN2CCCN(C)CC2)cc1.I
InChIInChI=1S/C25H37N5.HI/c1-26-25(27-15-6-10-22-8-4-3-5-9-22)28-20-23-11-13-24(14-12-23)21-30-17-7-16-29(2)18-19-30;/h3-5,8-9,11-14H,6-7,10,15-21H2,1-2H3,(H2,26,27,28);1H
InChIKeyDBWMDCAZUKXSKI-UHFFFAOYSA-N
MW535.52 g/mol
LogP3.74
Rot. Bonds8

About 2-methyl-1-[[4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]methyl]-3-(3-phenylpropyl)guanidine;hydroiodide

2-methyl-1-[[4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]methyl]-3-(3-phenylpropyl)guanidine;hydroiodide (PubChem CID 111198739) has the molecular formula C25H38IN5 and a molecular weight of 535.52 g/mol. Its IUPAC name is 2-methyl-1-[[4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]methyl]-3-(3-phenylpropyl)guanidine;hydroiodide.

Molecular Properties

Compound Name2-methyl-1-[[4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]methyl]-3-(3-phenylpropyl)guanidine;hydroiodide
PubChem CID111198739
Molecular FormulaC25H38IN5
Molecular Weight535.52 g/mol
Exact Mass535.22
IUPAC Name2-methyl-1-[[4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]methyl]-3-(3-phenylpropyl)guanidine;hydroiodide
SMILESC/N=C(\NCCCc1ccccc1)NCc1ccc(CN2CCCN(C)CC2)cc1.I
InChIInChI=1S/C25H37N5.HI/c1-26-25(27-15-6-10-22-8-4-3-5-9-22)28-20-23-11-13-24(14-12-23)21-30-17-7-16-29(2)18-19-30;/h3-5,8-9,11-14H,6-7,10,15-21H2,1-2H3,(H2,26,27,28);1H
InChIKeyDBWMDCAZUKXSKI-UHFFFAOYSA-N
XLogP3.74
TPSA42.90 Ų
H-Bond Donors2
H-Bond Acceptors3
Rotatable Bonds8
Heavy Atoms31
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500535.52
LogP ≤ 53.74
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}

Analyze 2-methyl-1-[[4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]methyl]-3-(3-phenylpropyl)guanidine;hydroiodide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-methyl-1-[[4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]methyl]-3-(3-phenylpropyl)guanidine;hydroiodide?
The IUPAC name of 2-methyl-1-[[4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]methyl]-3-(3-phenylpropyl)guanidine;hydroiodide (CID 111198739) is 2-methyl-1-[[4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]methyl]-3-(3-phenylpropyl)guanidine;hydroiodide.
What is the SMILES notation for 2-methyl-1-[[4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]methyl]-3-(3-phenylpropyl)guanidine;hydroiodide?
The canonical SMILES for 2-methyl-1-[[4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]methyl]-3-(3-phenylpropyl)guanidine;hydroiodide is C/N=C(\NCCCc1ccccc1)NCc1ccc(CN2CCCN(C)CC2)cc1.I.
What is the InChIKey of 2-methyl-1-[[4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]methyl]-3-(3-phenylpropyl)guanidine;hydroiodide?
The InChIKey is DBWMDCAZUKXSKI-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H37N5.HI/c1-26-25(27-15-6-10-22-8-4-3-5-9-22)28-20-23-11-13-24(14-12-23)21-30-17-7-16-29(2)18-19-30;/h3-5,8-9,11-14H,6-7,10,15-21H2,1-2H3,(H2,26,27,28);1H.
What are the key properties of 2-methyl-1-[[4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]methyl]-3-(3-phenylpropyl)guanidine;hydroiodide?
2-methyl-1-[[4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]methyl]-3-(3-phenylpropyl)guanidine;hydroiodide has a molecular weight of 535.52 g/mol, XLogP of 3.74, 8 rotatable bonds, 2 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 2-methyl-1-[[4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]methyl]-3-(3-phenylpropyl)guanidine;hydroiodide is sourced from PubChem (CID 111198739), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).